Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
72,838,954
-
Share change
-
-14,272,242
-
Total reported value
-
$11,295,952,445
-
Put/Call ratio
-
86%
-
Price per share
-
$155.01
-
Number of holders
-
559
-
Value change
-
-$2,132,897,022
-
Number of buys
-
306
-
Number of sells
-
234
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q1 2020
As of 31 Mar 2020 Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) had 559 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 72,838,954 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WADDELL & REED FINANCIAL INC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., Ensign Peak Advisors, Inc, and Capital World Investors.
This table shows 559 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.